Marimed (MRMD) COO Timothy Shaw Receives RSUs; 22,523 Shares Withheld

What Happened

• Timothy Shaw, Chief Operating Officer of Marimed Inc. (MRMD), had 65,000 restricted stock units (RSUs convert/derivative) convert into common stock on September 1, 2026. The conversion is reported as an exercise/conversion of a derivative (code M) resulting in 65,000 shares acquired at $0.00.
• To satisfy tax withholding obligations, 22,523 of those shares were withheld/disposed (code F) at $0.08 per share, totaling $1,838. After withholding, the net shares delivered from this grant were 42,477 (65,000 converted − 22,523 withheld).
• This is a routine vesting/tax-withholding transaction (receipt of award with shares withheld), not an open-market purchase or sale of additional shares.

Key Details

• Transaction date: 2026-09-01.
• Conversions: 65,000 shares acquired via derivative conversion at $0.00 per share (code M).
• Withholding: 22,523 shares withheld/disposed for tax at $0.08 per share, proceeds $1,838 (code F).
• Net shares received from this grant: 42,477.
• Footnotes: RSUs convert one-for-one to common stock (F1). Shares were withheld by the issuer to satisfy tax obligations (F2). The RSUs were originally granted on 9/1/2023 and there are no remaining RSUs under that grant (F4). A separate footnote (F3) disclaims beneficial ownership of certain shares held in an irrevocable trust for the benefit of the reporting person’s children.
• Filing timeliness: No late filing indicated.

Context

• This was a vesting/award event (RSUs converting to common stock) with a portion withheld to cover taxes — a common, routine insider event that does not necessarily signal a change in insider sentiment.
• For clarity: code M indicates conversion/exercise of a derivative (here, RSUs converting to shares); code F indicates shares were withheld to pay tax liabilities (not an open-market sale).